Finally, serum levels of BAFF were found decreased in CIDP, although this may be confounded by the presence of anti-BAFF antibodies in the IVIg preparations that these patients had received for therapy. Here, TNFSF13B is linked to chronic inflammatory demyelinating polyradiculoneuropathy.